Forgot your password?

Forgot your username?


Global News Wire: Pluristem Therapeutics Forms Strategic Alliance with ChaBio & Diostech

Posted on 17 Jul 2013
Pluristem Therapeutics (PSTI) is a developer of placenta-based cell therapies. They have just formed a strategic alliance with Cha Bio&Diostech.

Global News Wire: Novavax Initiating Human Clinical Trials for H7N9 Virus

Posted on 17 Jul 2013
Novavax, Inc (NVAX) is a clinical-stage biopharmaceutical company that strives to create novel vaccines to treat a broad spectrum of diseases around the world.

Pharma Live: Cytokinetics amending errors in Amyotrophic Lateral Sclerosis Phase IIB Study

Posted on 17 Jul 2013
Cytokinetics (CYTK) is a clinical stage biotechnology company that focuses on the discovery and development of novel molecular therapeutics in relation to muscle function.

Cognoptix: Simple Eye-Scan Test a Powerful Tool for Diagnosing Alzheimer’s Disease

Posted on 16 Jul 2013
Cognoptix and its technology have the ability to overhaul commonly accepted Alzheimer's Disease diagnostic practices, providing a tool to diagnose the disease at an early stage, thereby increasing the efficacy of current therapies.

BioCentury: Orexo is Dissolving Away Opioid Addiction with New Medication

Posted on 16 Jul 2013
Orexo is an emerging specialty pharmaceutical company in route to enter the market with their new medication Zubsolv; an oral medication that dissolves under the tongue to treat opioid addiction.

“The Value Proposition of the JOBS Act and Reg A” How Will Capital Market Structures Assess Valuation for Smaller Medical Technology Companies After the JOBS Act?

Posted on 16 Jul 2013
There has been much debate of how the capital market landscape is looking to shape up for bioscience companies with the impending implementation of the JOBS Act.  However, even greater debate rages as to what the landscape will look like after the provisions are put into effect. One t

Complexa: Novel Treatment for Contrast-Induced Acute Kidney Injury

Posted on 16 Jul 2013
The Contrast Induced Kidney market is a large one, at about $500 million. This is due to the fact that Acute Kidney Injury affects 3-7% of all patients admitted into hospitals and about 25-30% of patients admitted into the Intensive Care Unit. Complexa's technology has the potential t

Greenestone Healthcare Corp. CEO Discusses Valuation for Canadian Medical Clinics

Posted on 26 Jun 2013
GreeneStone Healthcare Corp. (OTCBB: GRST) operates medical clinics in Ontario, Canada. GreeneStone adds capacity to an increasingly stretched provincial healthcare system, and provides private alternatives to publicly under-serviced niches. Greenestone President and CEO Shawn Leon sp

Metabiomics’ Exec: Test Can Be a Cheaper and More Accurate Alternative to Colonoscopies

Posted on 25 Jun 2013
Metabiomics is developing a noninvasive screening test for colon polyps in colorectal cancer based on human microbiome markers. In an interview with OneMedRadio, Gregory Kuehn, Vice President of Business Development at Metabiomics, explained that the preliminary data showed “sensitivi